Press Releases

12/21/2007
Labopharm enters into agreement for US$25 million debt financing

12/10/2007
Labopharm to present at RBC Capital Markets 2007 Healthcare Conference

11/21/2007
Labopharm receives FDA response to appeal of Approvable Letter for once-daily tramadol

11/9/2007
Labopharm Reports Results for Third Quarter Fiscal 2007

10/30/2007
Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference

10/26/2007
Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)

10/16/2007
Labopharm to host webcast presentation on once-daily trazodone

10/15/2007
Labopharm appeals FDA's decision on once-daily tramadol

9/25/2007
Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug

9/24/2007
Labopharm provides update on U.S. regulatory process for once-daily Tramadol

9/19/2007
Labopharm to present at the 2007 UBS Global Life Sciences Conference and the CIBC 6TH annual Eastern Institutional Investor Conference

9/17/2007
Paladin and Labopharm Launch Tridural(TM) Once-Daily Tramadol Product in Canada

9/14/2007
Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy

8/9/2007
Labopharm reports results for second quarter fiscal 2007

8/2/2007
Labopharm to present at Canaccord Adams' 27th Global Growth Conference

7/26/2007
Labopharm to host conference call Thursday, August 9, 2007 at 8:30 a.m. (ET)

7/12/2007
Labopharm and Paladin Complete Canadian Licensing and Distribution Agreement for Labopharm's Once-Daily Tramadol Product

7/11/2007
Labopharm Completes South Korean Licensing and Distribution Agreement for Once-Daily Tramadol

6/29/2007
Labopharm to present poster on dose titration of once-daily tramadol at 3rd International Forum on Pain Medicine

6/29/2007
Labopharm meets with FDA to discuss second Approvable Letter for once-daily tramadol

6/18/2007
Labopharm's Once-Daily Tramadol Approved for Sale in Canada

6/7/2007
Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Trazodone

5/31/2007
Labopharm Receives Second Approvable Letter from FDA for Once-Daily Tramadol

5/23/2007
Labopharm to present at Bank of America 2007 Health Care Conference to be held in Las Vegas, Nevada

5/9/2007
Labopharm reports results for first quarter fiscal 2007

4/27/2007
Labopharm to host conference call Wednesday, May 9, 2007 at 8:30 A.M. (ET)

4/27/2007
Labopharm announces details of 2007 Annual Meeting

4/5/2007
Labopharm to present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

3/21/2007
Labopharm to present at Scotia Capital Spring Growth Conference

2/19/2007
Labopharm appoints new member to Board of Directors

2/16/2007
Labopharm reports results for fourth quarter and year end fiscal 2006

2/15/2007
Labopharm appoints Vice President Sales and Marketing

2/9/2007
Labopharm to present data at the 23rd Annual American Academy of Pain Medicine Meeting

2/5/2007
Labopharm To Host Conference Call Friday, February 16, 2007 at 8:30 A.M. (ET)

1/29/2007
Labopharm to present at Merrill Lynch Global Healthcare Conference in New York

1/16/2007
FDA accepts Labopharm's response to approvable letter for once-daily tramadol as complete

1/9/2007
Labopharm Provides Update on Roll Out of Once-daily Tramadol Across Europe